Results 141 to 150 of about 1,649 (190)

Rare Mould Fungaemia at a Tertiary Academic Hospital in Athens, Greece: A 15-Year Survey and Literature Review. [PDF]

J Fungi (Basel)
Siopi M, Alevra A, Mitsopoulos D, Pournaras S, Meletiadis J.   +4 more
europepmc   +1 more source

Fosmanogepix for the Treatment of Invasive Mold Diseases Caused by Aspergillus Species and Rare Molds: A Phase 2, Open-Label Study (AEGIS). [PDF]

Clin Infect Dis
Hodges MR, Tawadrous M, Cornely OA, Thompson GR, Slavin MA, Maertens JA, Dadwal SS, Rahav G, Hazel S, Almas M, Jakate A, Pypstra R.   +11 more
europepmc   +1 more source

Diagnosis and management of invasive fungal infections due to non-Aspergillus moulds. [PDF]

J Antimicrob Chemother
Morrissey CO.
europepmc   +1 more source

Comparative volatilomics identifies ubiquitous sulfur compounds inhibiting the fungal pathogen <i>Rasamsonia argillacea</i>. [PDF]

Microbiol Spectr
Adam D, Bensaada D, Stulanovic N, Focant J-F, Stefanuto P-H, Rigali S.   +5 more
europepmc   +1 more source

The New Path Forward for Prior Authorizations: Navigating Differences in the Accepted Standards of Care, Society Guidelines, and FDA-approved Indications. [PDF]

Open Forum Infect Dis
Desai AN, Rauseo A, Rogan GN, Spec A, Thompson GR.   +4 more
europepmc   +1 more source

Detection and Management of Invasive Mold Disease in Pediatric Hematological Cancer Patients. [PDF]

Infect Drug Resist
Bochennek K, Rohm T, Lehrnbecher T.
europepmc   +1 more source

Fungal infections in burn patients: The rise of Fusarium as the most prevalent in a burn center in Mexico City. [PDF]

Med Mycol
González Guerrero MC, Mondragón Eguiluz JA, García Hernández ML, Cerón González G, Colín Castro CA, Cruz Arenas E, Guerrero Almeida ML, Vanegas Rodríguez ES, Franco Cendejas R, López Jácome LE.   +9 more
europepmc   +1 more source

Review of the novel antifungal drug olorofim (F901318). [PDF]

BMC Infect Dis
Vanbiervliet Y, Van Nieuwenhuyse T, Aerts R, Lagrou K, Spriet I, Maertens J.   +5 more
europepmc   +1 more source